Pulmonary hypertension associated with cardiopulmonary bypass and cardiac surgery
© 2022 Wiley Periodicals LLC..
BACKGROUND AND AIM: Pulmonary hypertension (PH) is frequently associated with cardiovascular surgery and is a common complication that has been observed after surgery utilizing cardiopulmonary bypass (CPB). The purpose of this review is to explain the characteristics of PH, the mechanisms of PH induced by cardiac surgery and CPB, treatments for postoperative PH, and future directions in treating PH induced by cardiac surgery and CPB using up-to-date findings.
METHODS: The PubMed database was utilized to find published articles.
RESULTS: There are many mechanisms that contribute to PH after cardiac surgery and CPB which involve pulmonary vasomotor dysfunction, cyclooxygenase, the thromboxane A2 and prostacyclin pathway, the nitric oxide pathway, inflammation, and oxidative stress. Furthermore, there are several effective treatments for postoperative PH within different types of cardiac surgery.
CONCLUSIONS: By possessing a deep understanding of the mechanisms that contribute to PH after cardiac surgery and CPB, researchers can develop treatments for clinicians to use which target the mechanisms of PH and ultimately reduce and/or eliminate postoperative PH. Additionally, learning about the most up-to-date studies regarding treatments can allow clinicians to choose the best treatments for patients who are undergoing cardiac surgery and CPB.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:37 |
|---|---|
| Enthalten in: |
Journal of cardiac surgery - 37(2022), 12 vom: 18. Dez., Seite 5269-5287 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Fayad, Fayez H [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Cardiac surgery |
|---|
| Anmerkungen: |
Date Completed 05.01.2023 Date Revised 11.01.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/jocs.17160 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34892352X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34892352X | ||
| 003 | DE-627 | ||
| 005 | 20231226041428.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/jocs.17160 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1163.xml |
| 035 | |a (DE-627)NLM34892352X | ||
| 035 | |a (NLM)36378925 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Fayad, Fayez H |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Pulmonary hypertension associated with cardiopulmonary bypass and cardiac surgery |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.01.2023 | ||
| 500 | |a Date Revised 11.01.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022 Wiley Periodicals LLC. | ||
| 520 | |a BACKGROUND AND AIM: Pulmonary hypertension (PH) is frequently associated with cardiovascular surgery and is a common complication that has been observed after surgery utilizing cardiopulmonary bypass (CPB). The purpose of this review is to explain the characteristics of PH, the mechanisms of PH induced by cardiac surgery and CPB, treatments for postoperative PH, and future directions in treating PH induced by cardiac surgery and CPB using up-to-date findings | ||
| 520 | |a METHODS: The PubMed database was utilized to find published articles | ||
| 520 | |a RESULTS: There are many mechanisms that contribute to PH after cardiac surgery and CPB which involve pulmonary vasomotor dysfunction, cyclooxygenase, the thromboxane A2 and prostacyclin pathway, the nitric oxide pathway, inflammation, and oxidative stress. Furthermore, there are several effective treatments for postoperative PH within different types of cardiac surgery | ||
| 520 | |a CONCLUSIONS: By possessing a deep understanding of the mechanisms that contribute to PH after cardiac surgery and CPB, researchers can develop treatments for clinicians to use which target the mechanisms of PH and ultimately reduce and/or eliminate postoperative PH. Additionally, learning about the most up-to-date studies regarding treatments can allow clinicians to choose the best treatments for patients who are undergoing cardiac surgery and CPB | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a cardiac surgery | |
| 650 | 4 | |a cardiopulmonary bypass | |
| 650 | 4 | |a etiology | |
| 650 | 4 | |a mechanisms | |
| 650 | 4 | |a pulmonary hypertension | |
| 650 | 4 | |a treatments | |
| 700 | 1 | |a Sellke, Frank W |e verfasserin |4 aut | |
| 700 | 1 | |a Feng, Jun |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of cardiac surgery |d 1996 |g 37(2022), 12 vom: 18. Dez., Seite 5269-5287 |w (DE-627)NLM013294970 |x 1540-8191 |7 nnns |
| 773 | 1 | 8 | |g volume:37 |g year:2022 |g number:12 |g day:18 |g month:12 |g pages:5269-5287 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/jocs.17160 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 37 |j 2022 |e 12 |b 18 |c 12 |h 5269-5287 | ||